Thomas Natoli

Company: Dyne Therapeutics

Job title: Senior Director

Seminars:

FORCE™ Platform Enables TFR1-Mediated Delivery of Therapeutics for Serious Muscle Diseases 4:30 pm

Discovering key elements of the platform and considerations for oligonucleotide conjugate selection Understanding the FORCE translation into the clinic and the ACHIEVE & DELIVER trial data in DM1 and DMD Reviewing the FORCE efficacy in preclinical models of FSHDRead more

day: Day One